Aptus Capital Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.79M Buy
31,963
+1,600
+5% +$139K 0.02% 359
2025
Q1
$2.73M Buy
30,363
+2,184
+8% +$196K 0.03% 352
2024
Q4
$2.27M Buy
28,179
+16,679
+145% +$1.34M 0.02% 372
2024
Q3
$1.04M Buy
11,500
+1,487
+15% +$134K 0.02% 402
2024
Q2
$788K Buy
10,013
+1,774
+22% +$140K 0.01% 423
2024
Q1
$718K Buy
8,239
+1,729
+27% +$151K 0.01% 439
2023
Q4
$536K Buy
6,510
+756
+13% +$62.3K 0.01% 369
2023
Q3
$451K Buy
5,754
+2,901
+102% +$227K 0.01% 400
2023
Q2
$251K Sell
2,853
-160
-5% -$14.1K 0.01% 433
2023
Q1
$245K Buy
3,013
+84
+3% +$6.83K 0.01% 426
2022
Q4
$228K Sell
2,929
-32
-1% -$2.49K 0.01% 454
2022
Q3
$242K Buy
2,961
+682
+30% +$55.7K 0.01% 408
2022
Q2
$206K Sell
2,279
-49,457
-96% -$4.47M 0.01% 363
2022
Q1
$5.74M Buy
51,736
+7,427
+17% +$824K 0.14% 86
2021
Q4
$4.58M Buy
44,309
+6,325
+17% +$654K 0.14% 94
2021
Q3
$4.76M Buy
37,984
+7,689
+25% +$964K 0.12% 70
2021
Q2
$3.76M Buy
30,295
+1,084
+4% +$135K 0.11% 78
2021
Q1
$3.45M Buy
29,211
+813
+3% +$96K 0.12% 71
2020
Q4
$3.33M Buy
28,398
+4,091
+17% +$479K 0.15% 71
2020
Q3
$2.53M Buy
24,307
+518
+2% +$53.8K 0.13% 79
2020
Q2
$2.18M Buy
+23,789
New +$2.18M 0.14% 86